Investing in Avid Bioservices, Inc. (CDMO)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)3240.7047982
Intrinsic value (DCF)0.06-99
Graham-Dodd Method3.07-54
Graham Formula0.12-98

Company description

CDMO, or Catalent Inc., is a global pharmaceutical company that specializes in providing a variety of services to the pharmaceutical, biotechnology, and consumer health industries. These services include drug development, delivery technologies, and manufacturing solutions. The company has a strong presence in over 80 countries and has established itself as a leader in its field. CDMO's mission is to improve people's lives by enabling better treatments through their innovative and high-quality products and services. With a diverse portfolio of offerings, the company is well-positioned to support its customers through all stages of the drug development process. CDMO's commitment to innovation, quality, and customer service has allowed it to build lasting partnerships with some of the world's top pharmaceutical companies. Additionally, the company values corporate responsibility and sustainability, striving to make a positive impact on the communities it serves. CDMO continues to grow and evolve in an ever-changing pharmaceutical landscape, solidifying its position as a industry leader in drug development and delivery.